[125]I-Spectramide: A novel benzamide displaying potent and selective effects at the D2 dopamine receptor
Open Access
- 31 December 1989
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 45 (19), 1821-1829
- https://doi.org/10.1016/0024-3205(89)90523-7
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- In Vivo Measurement of Dopamine Receptors in Human Brain by Positron Emission Tomography Age and Sex DifferencesaAnnals of the New York Academy of Sciences, 1988
- In vitro binding properties and autoradiographic imaging of 3-iodobenzamide ([125I]-IBZM): A potential imaging ligand for D-2 dopamine receptors in spectLife Sciences, 1988
- Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the ratJournal of Pharmacy and Pharmacology, 1983
- 3H-dopamine binding to rat striatal D-2 and D-3 sites: Enhancement by magnesium and inhibition by guanine nucleotides and sodiumLife Sciences, 1982
- Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanismsJournal of Pharmacy and Pharmacology, 1980
- Cation regulation differentiates specific binding of [3 H]sulpiride and [3 H]spiperone to rat striatal preparationsJournal of Pharmacy and Pharmacology, 1980
- Specific binding of [3H]sulpiride to rat striatal preparationsJournal of Pharmacy and Pharmacology, 1979
- Multiple receptors for dopamineNature, 1979
- Substituted benzamides as cerebral dopamine antagonists in rodentsNeuropharmacology, 1977
- Sulpiride: A study of the effects on dopamine receptors in rat neostriatum and limbic forebrainLife Sciences, 1975